fda sued over tirzepatide confirms shortage is still over, gives compounders a grace period Lilly Wins Court Battle Against

Dual- and triple action approaches which simultaneously target multiple pathways, for example, GLP1R/GIP (tirzepatide), GLP1R/GIP/glucagon (retatrutide) or amylin/GLP1R (CagriSemra) appear more potent and may push weight reduction to the mid-20% range and possibly beyond, while oral options seek to deliver levels of efficacy seen with injectables

Can Retatrutide improve your mental health

Nearly half of seniors quit GLP-1 weight-loss drugs within a year

These benefits span multiple biological systems including the nervous, musculoskeletal and respiratory systems

Results Oral semaglutide was associated with improvements in quality-adjusted life expectancy of 0.09 quality-adjusted life years (QALYs) versus empagliflozin, 0.20 QALYs versus sitagliptin and 0.07 QALYs versus liraglutide